NASDAQ:TTOO T2 Biosystems (TTOO) Stock Price, News & Analysis $0.01 +0.01 (+2,400.00%) As of 11/9/2026 03:36 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesSEC Filings About T2 Biosystems Stock (NASDAQ:TTOO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get T2 Biosystems alerts:Sign Up Key Stats Today's Range$0.0007▼$0.0150-Day Range N/A52-Week Range$0.00▼$0.05Volume631 shsAverage Volume9,299 shsMarket Capitalization$210.43 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview T2 Biosystems, Inc. is a medical diagnostics company focused on developing and commercializing technologies for the rapid detection of sepsis-causing pathogens and antimicrobial resistance. Its products are designed to identify infections directly from whole-blood samples, potentially helping healthcare providers begin targeted treatment sooner than with conventional culture-based testing. The company’s principal platform is the T2Dx Instrument, an automated diagnostic system that uses proprietary T2 Magnetic Resonance technology. Tests available for the platform have included T2Bacteria, which detects several common bacterial pathogens associated with bloodstream infections, and T2Candida, which detects Candida species linked to candidemia. T2 Biosystems has also developed tests intended to identify antimicrobial-resistance markers and pathogens associated with other serious infections. Founded in 2006 and headquartered in Lexington, Massachusetts, T2 Biosystems markets its diagnostic products to hospitals, laboratories and other healthcare providers. The company serves customers in the United States and international markets through direct sales and distribution relationships. John Sperzel has served as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Receive TTOO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TTOO Stock News HeadlinesT2 Biosystems Inc.May 19, 2026 | marketwatch.comT2 Biosystems, Inc. Announces Intent to Complete Winding Down of OperationsFebruary 3, 2026 | finance.yahoo.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets. | Weiss Ratings (Ad)T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis ReportOctober 21, 2025 | finance.yahoo.comTTOO T2 Biosystems, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comT2 Biosystems Inc. (TTOO) After Hours QuoteJune 10, 2025 | nasdaq.comT2 Biosystems initiates major layoffs, seeks asset saleFebruary 22, 2025 | uk.investing.comMedical diagnostics firm T2 Biosystems cuts ‘substantially all’ workersFebruary 18, 2025 | bizjournals.comSee More Headlines TTOO Stock Analysis - Frequently Asked Questions How have TTOO shares performed this year? T2 Biosystems' stock was trading at $0.0050 at the beginning of the year. Since then, TTOO shares have increased by 100.0% and is now trading at $0.01. How were T2 Biosystems' earnings last quarter? T2 Biosystems, Inc. (NASDAQ:TTOO) released its earnings results on Monday, July, 29th. The medical equipment provider reported ($0.66) earnings per share for the quarter, beating analysts' consensus estimates of ($0.97) by $0.31. The medical equipment provider had revenue of $1.95 million for the quarter. Read the conference call transcript. When did T2 Biosystems' stock split? T2 Biosystems shares reverse split on the morning of Friday, October 13th 2023.The 1-100 reverse split was announced on Friday, October 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did T2 Biosystems IPO? T2 Biosystems (TTOO) raised $83 million in an initial public offering on Wednesday, August 6th 2014. The company issued 5,200,000 shares at $15.00-$17.00 per share. How do I buy shares of T2 Biosystems? Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of T2 Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that T2 Biosystems investors own include Bionano Genomics (BNGO), Tesla (TSLA), NIO (NIO), Sorrento Therapeutics (SRNE), NVIDIA (NVDA), SNDL (SNDL) and Canopy Growth (CGC). Company Calendar Today11/10/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TTOO CIK1492674 Webwww.t2biosystems.com Phone(781) 761-4646Fax781-357-3080Employees113Year Founded2006Profitability EPS (Trailing Twelve Months)($3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.08 million Net Margins-563.16% Pretax Margin-559.52% Return on EquityN/A Return on Assets-174.06% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.24 Sales & Book Value Annual Sales$7.68 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value($6.91) per share Price / Book0.00Miscellaneous Outstanding Shares21,043,000Free Float21,037,000Market Cap$210.43 thousand OptionableNo Data Beta8.42 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:TTOO) was last updated on 11/9/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIPO mania is back - here's the income play I'm watching closelySpaceX, Anthropic, and OpenAI are leading a new wave of blockbuster IPOs. Tim Plaehn found a quiet fund that l...Investors Alley | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | SponsoredBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
